Clorox reports Q3 adjusted EPS $1.64, consensus $1.55

Reports Q3 revenue $1.67B, consensus $1.67B. “Our third-quarter results were mixed, with continued momentum in some parts of our portfolio and slower-than-anticipated market share recovery in others,” said Chair and CEO LindaRendle. “Looking ahead, we recognize there is more work to do in what continues to be a challenging consumer and cost environment. We’re focused on improving execution to accelerate market share progress in challenging areas while continuing to invest behind areas of strength. We’re excited about the opportunities ahead as we expand our innovation pipeline and integrate Purell into our portfolio, reinforcing our confidence in our ability to deliver more consistent, profitable growth over time.”